LOL! You are right - there are many unknowns which can

New Post Public Reply Private Reply Replies (1) Message Board
Paul Jackson Buildit #10387
334
LOL! You are right - there are many unknowns which can possibly jeopardize the $2M net tangible assets needed for the uplist. And you are totally right that we should look at the uplist as a result to positive business practices/progress, not the catalyst for the stock.

A few things I'd like to mention that helps the $2M tangible assets -

1. Last Q net loss was $9.2MM, if you look at Note 10 of the 10Q, the $9.2M includes $3,033,820 increase in derivative liability during the quarter because of Veneto...so, with Veneto violation, GNBT is no longer liable for the derivative liability, so the $9.2M loss should have been $6.2M loss instead.

2. Because of the Veneto violation, $6M liability will be wiped out...the way to wipe out an liability on GNBT's books is to increase other income...so, next 10Q should reflect extra $6M in other income under "change in fair value of derivative liability."

3. The $2.2MM bridge loan - it will show up as cash of $2.2M and Note payable of $2.2M, so the effect on net tangible assets is zero. Also, I don't think it is part of the $40M. Please see notes from 10Q, copied and pasted here -

From 10Q -

On November 25, 2019, the Company entered an Equity Purchase Agreement with an investor to purchase up to $40,00,000 of the Company’s stock at 92% of the market price for the period of five (5) consecutive trading days immediately subject to a put notice on such date on which the Purchase Price is calculated in accordance with the terms and conditions of this Agreement and in which 1,228,501 shares of common stock (“Commitment Shares”) upon signing will be issued to an investor.

On December 5, 2019, we closed under a securities purchase agreement with an investor pursuant to which we sold a convertible note bearing interest at 12% per year in the principal amount of $2,200,000. The purchase price of the note was $2,000,000 and the remaining $200,000 of principal amount represents original issue discount and issued 100,000 shares of common stock for the commitment.

4. Joe mentioned during the 11/29 cc, they are hoping to raise $30M more, but some investors will only invest after the S1 is filed

Copied and pasted from 11/29 cc -

Joe said -
We have definitive documents for $40 million in equity. That will give us enough capital over the next two or three years to build everything we need. We're not going to stop there--the goal is 70, we believe we can get there. I would like to see the share price go up a little bit more. But I will say we will file the S-1 immediately--hopefully, by the end of next week. And then we can add to it if we're able to get one of the other interested funds that requires the S-1 to be filed to invest.

SO, in summary, you are right that there are many unknowns, but maybe $2M net tangible assets is still possible...



Buildit wrote -

Purely for fun, and not trying to be an ass... I’ll continue the speculation

Just a few other items I can think of that we know:
Last Q Op Loss was $4.55MM, Net Loss was $9.2MM, and the $2.5MM bridge loan will come out of the S-1 $ but not show on the last Q liabilities. So that could wipe out the $7.8MM or more.

A few things we don’t know:
Depending how much $ Joe is spending now on attorneys/consultants, etc this Q, that could be a decent number.
How will ALTuCell affect assets and liabilities?
Did any obligations roll up in cost due to the low stock price that is being used to find many things right now?

Again, I think we should look at the uplist as a result to positive business practices/progress, not the catalyst for the stock. That was a nice thought while it lasted, but execution is the key now...

Read More: https://investorshangout.com/post/newpost/622...z69SbLIMvd

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 22

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 15

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 28

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 19

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 24

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 11

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 23

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Excitement Builds for the 2025 Special Olympics Winter Games

Updated Category News Views 612

The Opening Ceremony of the 2025 Special Olympics World Winter Games In a grand celebration last night, the lights illuminated the Inalpi Arena, marking the commencement of the 2025 Special Olympics World Winter Games in Turin. This event is poised to become the largest sports and humanitarian gathering of the year. With the lighting of the "Flame of Hope," over 1,500...

Continue Reading
Embracing Pet Ownership: Older Canadians Thrive with Pets

Updated Category News Views 173

Discover the Joy of Pet Ownership Among Older Canadians Pet ownership can transform lives, and for older Canadians, the companionship of a furry friend offers numerous emotional and physical benefits. According to a recent survey by Ipsos for HomeEquity Bank, it has become evident that many Canadians aged 55 and over understand the significant value of sharing their lives...

Continue Reading
Salus Scientific: A Solid Stand Against Industry Recalls Risk

Updated Category News Views 283

Reputation on the Line Nothing shakes the confidence of hospitals like a recall. You know how it is—one day, everything's rolling along fine, and then BAM, safety issues pop up like bad news at a family dinner. Take Salus Scientific, for instance. They’re standing firm against the wave of issues unraveling other companies in radiation protection gear. They’ve got a...

Continue Reading
Investigation into Potential Violations of Securities Laws

Updated Category News Views 276

Investigation into Potential Violations of Securities Laws Halper Sadeh LLC, a dedicated investor rights law firm, has launched an investigation into several companies regarding potential breaches of fiduciary duties and violations of federal securities laws. This initiative particularly aims to benefit shareholders of Old Point Financial Corporation, ProAssurance...

Continue Reading
Concerns Rise Over Fluoride in Children's Oral Products

Updated Category News Views 150

Lawsuits Target Leading Oral Health Brands Recent legal troubles have emerged for Procter & Gamble and Colgate-Palmolive regarding their children's oral care products. Parents are voicing their concerns through multiple lawsuits against these industry giants, claiming that fluoride in toothpaste and mouth rinses poses health risks for young children. Key Products Under...

Continue Reading